Patents Assigned to Britannia Pharmaceuticals Ltd.
-
Patent number: 11766431Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.Type: GrantFiled: April 30, 2021Date of Patent: September 26, 2023Assignee: Britannia Pharmaceuticals Ltd.Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
-
Patent number: 11026938Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.Type: GrantFiled: January 10, 2014Date of Patent: June 8, 2021Assignee: Britannia Pharmaceuticals Ltd.Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
-
Patent number: 10159792Abstract: The present disclosure refers to drug administering devices that may include a casing front portion in which a cavity is formed and which includes front connecting means, a drug container received in the cavity, a casing rear portion comprising a piston rod which is displaceable into the cavity, and rear connecting means for releasably connecting to the front connecting means, wherein said casing front portion comprises at least two members which, in locking engagement with each other, delimit a front portion of the cavity and a rear portion having a cross section which is narrower than that of the front portion and too narrow for the drug container to pass.Type: GrantFiled: April 25, 2014Date of Patent: December 25, 2018Assignee: BRITANNIA PHARMACEUTICALS LTD.Inventor: Rachael Nowak
-
Publication number: 20180098981Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.Type: ApplicationFiled: December 13, 2017Publication date: April 12, 2018Applicant: BRITANNIA PHARMACEUTICALS LTD.Inventors: Michael DEY, Joel RICHARD, Marie-Madeleine BARONNET, Nathalie MONDOLY, Laurent BERTOCCHI, Jeremiah HARNETT
-
Publication number: 20160106922Abstract: The present disclosure refers to drug administering devices that may include a casing front portion in which a cavity is formed and which includes front connecting means, a drug container received in the cavity, a casing rear portion comprising a piston rod which is displaceable into the cavity, and rear connecting means for releasably connecting to the front connecting means, wherein said casing front portion comprises at least two members which, in locking engagement with each other, delimit a front portion of the cavity and a rear portion having a cross section which is narrower than that of the front portion and too narrow for the drug container to pass.Type: ApplicationFiled: April 25, 2014Publication date: April 21, 2016Applicant: BRITANNIA PHARMACEUTICALS LTD.Inventor: Rachael Nowak
-
Publication number: 20140128422Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.Type: ApplicationFiled: January 10, 2014Publication date: May 8, 2014Applicant: Britannia Pharmaceuticals Ltd.Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
-
Publication number: 20110308516Abstract: The invention provides a delivery device (10) for a medicament comprising: a housing (50), a receptacle (54) holding a medicament (80) in the form of a powder; and a source of propellant (53), characterized in that the housing (50) provides an inlet (63) and an outlet (56) for the receptacle (54) wherein the inlet (63) is in fluid communication with the source of propellant (53) and is directed against the medicament (80) and the outlet (56) is spaced from the medicament (80) to allow aerosolisation of the medicament (80); the device (10) provides improved delivery efficiency, particularly a delivered fine particle fraction of greater than 20% by weight.Type: ApplicationFiled: February 2, 2011Publication date: December 22, 2011Applicant: Britannia Pharmaceuticals Ltd.Inventors: Robert Price, John Nicholas Staniforth, Derek Alan Woodcock, Paul Michael Young
-
Patent number: 7473416Abstract: A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).Type: GrantFiled: November 1, 2004Date of Patent: January 6, 2009Assignee: Britannia Pharmaceuticals, Ltd.Inventors: Audrey Egerton Hills, legal representative, Derek Alan Woodcock, Brian Andrew Hills
-
Patent number: 6719960Abstract: A medicament is disclosed for reducing the risk of cross-healing (“adhesions”) after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.Type: GrantFiled: August 10, 2000Date of Patent: April 13, 2004Assignee: Britannia Pharmaceuticals Ltd.Inventors: Brian Andrew Hills, Derek Alan Woodcock